A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase‐based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia
British Journal of Clinical Pharmacology · 2023
DOI: 10.1111/bcp.15868 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Qiufen Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Innovation Program of Hunan Province, National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Methotrexate (MTX) is recognized for its potential to induce hepatotoxicity, commonly manifested by elevated alanine aminotransferase (ALT) levels. However, the quantitative relationship between the pharmacokinetics (PK) of MTX and ALT‐based hepatotoxicity remains unclear. This study aimed to develop a semimechanistic PK/pharmacodynamic (PD) model to characterize the MTX‐induced hepatotoxicity based on ALT in paediatric patients with acute lymphoid leukaemia.
Methods
A retrospective study was conducted on paediatric patients who received high‐dose (3–5 g/m 2 ) MTX treatment. MTX concentrations were assessed at 24‐h intervals until the concentration dropped below 0.1 μmol/L. ALT concentrations were measured both before and after MTX administration. A population PK model was initially developed, which was later connected to a semimechanistic hepatotoxicity model.
Results
The PK model was developed using 354 MTX concentrations obtained from 51 patients, while the PD model was constructed using 379 ALT concentrations collected from 48 patients. The optimal PK model for MTX consisted of a 2‐compartment structure, where body surface area served as a covariate for clearance and central volume of distribution. An indirect response model coupled to a liver injury signal transduction model was developed to describe the dynamics of ALT after MTX administration. The drug effect was adequately described by a linear model, exhibiting considerable interoccasion variability for each treatment session. No significant covariates were identified to have an impact on the PD parameters.
Conclusion
A semimechanistic model was developed to describe ALT‐based hepatotoxicity of MTX, and it has the potential to serve as a valuable tool for characterizing drug‐induced hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
- Postdoctoral Research Station of Clinical Medicine and Department of Paediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Feifan Xie
Förderung
- Science and Technology Innovation Program of Hunan Province
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation of China
- Natural Science Foundation of Changsha City in Hunan Province of China
- Science and Technology Program of Hunan Province
Zitieren
APA
Yin, Q., Cheng, Z., Yang, M., Wang, S., & Xie, F. (2023). A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase‐based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15868
Vancouver
Yin Q, Cheng Z, Yang M, Wang S, Xie F. A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase‐based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15868
BibTeX
@article{Yin2023,
author = {Yin, Qiufen and Cheng, Zeneng and Yang, Minghua and Wang, Shengfeng and Xie, Feifan},
title = {A semimechanistic pharmacokinetic/pharmacodynamic model for alanine aminotransferase‐based hepatotoxicity of methotrexate in paediatric patients with acute lymphoid leukaemia},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
doi = {10.1111/bcp.15868}
}
EUVIMED